Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HB72
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 193 | 197 | PF00656 | 0.230 |
CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.490 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.622 |
CLV_PCSK_PC1ET2_1 | 80 | 82 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.517 |
DOC_MAPK_gen_1 | 140 | 150 | PF00069 | 0.312 |
DOC_MAPK_HePTP_8 | 138 | 150 | PF00069 | 0.244 |
DOC_MAPK_MEF2A_6 | 141 | 150 | PF00069 | 0.381 |
DOC_PP1_RVXF_1 | 62 | 69 | PF00149 | 0.299 |
DOC_PP1_RVXF_1 | 99 | 106 | PF00149 | 0.288 |
DOC_PP2B_LxvP_1 | 216 | 219 | PF13499 | 0.346 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.389 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.292 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.697 |
DOC_WW_Pin1_4 | 114 | 119 | PF00397 | 0.391 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.739 |
LIG_BRCT_BRCA1_1 | 178 | 182 | PF00533 | 0.340 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.287 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.288 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.319 |
LIG_LIR_Gen_1 | 179 | 187 | PF02991 | 0.232 |
LIG_LIR_Gen_1 | 214 | 223 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 50 | 56 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 179 | 185 | PF02991 | 0.230 |
LIG_LIR_Nem_3 | 214 | 218 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 50 | 54 | PF02991 | 0.307 |
LIG_SH2_STAT3 | 206 | 209 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 56 | 59 | PF00017 | 0.383 |
LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.318 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.369 |
LIG_SUMO_SIM_anti_2 | 44 | 50 | PF11976 | 0.197 |
LIG_SUMO_SIM_par_1 | 44 | 50 | PF11976 | 0.383 |
LIG_TRFH_1 | 182 | 186 | PF08558 | 0.231 |
LIG_UBA3_1 | 184 | 188 | PF00899 | 0.363 |
MOD_CK1_1 | 50 | 56 | PF00069 | 0.410 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.442 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.559 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.576 |
MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.390 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.385 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.301 |
MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.428 |
MOD_N-GLC_1 | 200 | 205 | PF02516 | 0.426 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.465 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.274 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.286 |
MOD_PKA_1 | 152 | 158 | PF00069 | 0.344 |
MOD_Plk_1 | 163 | 169 | PF00069 | 0.293 |
MOD_Plk_1 | 200 | 206 | PF00069 | 0.224 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.636 |
MOD_Plk_4 | 163 | 169 | PF00069 | 0.325 |
MOD_Plk_4 | 41 | 47 | PF00069 | 0.429 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.289 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.698 |
MOD_ProDKin_1 | 114 | 120 | PF00069 | 0.391 |
MOD_SUMO_for_1 | 9 | 12 | PF00179 | 0.575 |
MOD_SUMO_rev_2 | 193 | 200 | PF00179 | 0.222 |
TRG_DiLeu_BaLyEn_6 | 216 | 221 | PF01217 | 0.346 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P990 | Leptomonas seymouri | 65% | 100% |
A0A0S4JMC1 | Bodo saltans | 38% | 100% |
A0A1X0PAV6 | Trypanosomatidae | 53% | 100% |
A0A3S7X8D8 | Leishmania donovani | 79% | 100% |
A0A422MZF8 | Trypanosoma rangeli | 51% | 100% |
A4IAC0 | Leishmania infantum | 79% | 100% |
C9ZLX2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9B5E3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |
Q4Q2J0 | Leishmania major | 77% | 100% |